Usnoflast

· Zydus Therapeutics Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Usnoflast, covering 2026-02-05 to 2026-02-05. Get the full timeline:

Most recent: Clinical Trial Update: Usnoflast Neuromuscular Investigation for Treatment Efficacy in Amyotrophic Lateral Sclerosis [Phase 2]